Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tarsus Pharmaceuticals (TARS) Asset Utilization Ratio (2021 - 2025)

Tarsus Pharmaceuticals has reported Asset Utilization Ratio over the past 5 years, most recently at 0.82 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.82 for Q4 2025, up 69.45% from a year ago — trailing twelve months through Dec 2025 was 0.82 (up 69.45% YoY), and the annual figure for FY2025 was 0.96, up 68.78%.
  • Asset Utilization Ratio for Q4 2025 was 0.82 at Tarsus Pharmaceuticals, up from 0.71 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for TARS hit a ceiling of 0.82 in Q4 2025 and a floor of 0.06 in Q2 2023.
  • Median Asset Utilization Ratio over the past 5 years was 0.21 (2021), compared with a mean of 0.28.
  • Biggest five-year swings in Asset Utilization Ratio: tumbled 77.06% in 2022 and later skyrocketed 643.11% in 2024.
  • Tarsus Pharmaceuticals' Asset Utilization Ratio stood at 0.31 in 2021, then crashed by 63.99% to 0.11 in 2022, then plummeted by 41.22% to 0.07 in 2023, then skyrocketed by 643.11% to 0.49 in 2024, then skyrocketed by 69.45% to 0.82 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.82 (Q4 2025), 0.71 (Q3 2025), and 0.59 (Q2 2025) per Business Quant data.